Skp2-MacroH2A1-CDK8 axis orchestrates G2/M transition and tumorigenesis

Dazhi Xu, Chien Feng Li, Xian Zhang, Zhaohui Gong, Chia Hsin Chan, Szu Wei Lee, Guoxiang Jin, Abdol Hossein Rezaeian, Fei Han, Jing Wang, Wei Lei Yang, Zi Zhen Feng, Wei Chen, Ching Yuan Wu, Ying Jan Wang, Lu Ping Chow, Xiao Feng Zhu, Yi Xin Zeng, Hui Kuan Lin

Research output: Contribution to journalArticlepeer-review

95 Scopus citations


Understanding the mechanism by which cell growth, migration, polyploidy, and tumorigenesis are regulated may provide important therapeutic strategies for cancer therapy. Here we identify the Skp2-macroH2A1 (mH2A1)-cyclin-dependent kinase 8 (CDK8) axis as a critical pathway for these processes, and deregulation of this pathway is associated with human breast cancer progression and patient survival outcome. We showed that mH2A1 is a new substrate of Skp2 SCF complex whose degradation by Skp2 promotes CDK8 gene and protein expression. Strikingly, breast tumour suppression on Skp2 deficiency can be rescued by mH2A1 knockdown or CDK8 restoration using mouse tumour models. We further show that CDK8 regulates p27 protein expression by facilitating Skp2-mediated p27 ubiquitination and degradation. Our study establishes a critical role of Skp2-mH2A1-CDK8 axis in breast cancer development and targeting this pathway offers a promising strategy for breast cancer therapy.

Original languageEnglish (US)
Article number6641
JournalNature Communications
StatePublished - Mar 2015

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)


Dive into the research topics of 'Skp2-MacroH2A1-CDK8 axis orchestrates G2/M transition and tumorigenesis'. Together they form a unique fingerprint.

Cite this